The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy

By Justenhoven Christina   Obazee Ofure   Brauch Hiltrud  

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 659-675

Future Medicine

Access to resources Recommend Favorite

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

By Ligibel Jennifer A.   Winer Eric P.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 215-221

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Immunotherapy and Hormone-therapy in Metastatic Breast Cancer: A Review and an Update

By  

Current Drug Targets, Vol. 17, Iss. 10, 2016-08 ,pp. : 1127-1139

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer

By Saladores Pilar H   Precht Jana C   Schroth Werner   Brauch Hiltrud   Schwab Matthias  

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 4, 2013-05 ,pp. : 349-365

Informa Healthcare

Access to resources Recommend Favorite

Change in Cycle 1 to Cycle 2 Haematological Counts Predicts Toxicity in Older Patients with Breast Cancer Receiving Adjuvant Chemotherapy

By Hurria Arti   Brogan Kelly   Panageas Katherine S.   Jakubowski Ann   Zauderer Marjorie   Pearce Carol   Norton Larry   Howard Jane   Hudis Clifford  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 709-715

Adis International

Access to resources Recommend Favorite